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Angiotensin II stimulates NHE3 activity by exocytic insertion
of the transporter: Role of PI 3-kinase.
Background. Low-concentration angiotensin II (Ang II) stim-
ulates Na/H exchanger 3 (NHE3) activity in renal proximal
tubule mainly via angiotensin II type 1 (AT1) receptors. The
mechanisms that mediate the increase in NHE3 activity elicited
by Ang II remain incompletely settled.
Methods. To assess a potential role of NHE3 trafficking in
the Ang II effect, NHE3 activity was measured by H-driven
initial rate of 22Na uptake resistant to 50 mol/L of the Na/H
exchange inhibitor cariporide (HOE642), and sensitive to 300
mol/L ethyl isopropyl amiloride (EIPA), in a model of cul-
tured proximal tubular cells (MKCC), in which functional apical
NHE3 and AT receptors are normally present. Apical expres-
sion of NHE3 protein was determined by cell surface biotinyla-
tion and immunoblotting.
Results. Ang II (1010 mol/L, 43 minutes) increased NHE3
activity and biotinylated NHE3 protein without any change in
total amount of NHE3 protein. Both effects were suppressed
by specific AT1 receptor antagonists. When 2-mercaptoethane-
sulphonic acid (MESNA) was used to cleave biotin from all
apical proteins, intracellular biotinylated NHE3 protein re-
mained unchanged after Ang II incubation compared to con-
trol. When sulfo-N-hydrosuccinimide (NHS)-acetate was used
first to block all apical reactive sites, an increase in biotinylated
NHE3 protein was observed following Ang II incubation. To
evaluate the role of phosphatidylinositol 3-kinase (PI 3-kinase),
the specific inhibitor wortmannin was used. It suppressed Ang
II–induced increase in NHE3 activity and trafficking. Further-
more, latrunculin B, inhibitor of actin filament polymerization,
prevented both Ang II stimulatory effects.
Conclusion. Ang II stimulates NHE3 activity, at least in
part, by exocytic insertion of the protein into the apical mem-
brane. This effect is mediated by PI 3-kinase and required
integrity of actin cytoskeleton.
Key words: kidney, NHE3 antiporter, angiotensin II, PI 3-kinase, pro-
tein trafficking.
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Angiotensin II (Ang II), at low physiologic systemic
concentrations, is well known to contribute to the regula-
tion of plasma volume and blood pressure, directly via
stimulation of NaCl reabsorption in the renal tubule,
and indirectly via stimulation of aldosterone secretion.
The main target of Ang II in the proximal tubule is the
apical Na/H exchange isoform NHE3, activated mainly
via angiotensin II type 1 (AT1) receptors [1–3]. Numer-
ous studies have identified several transduction pathways
involved in the effects of Ang II on NHE3, such as de-
crease in cyclic adenosine 3,5 monophosphate (camp)
[4] activation of protein kinase C (PKC) [3, 5–7], and
tyrosine kinase [8].
Several studies suggest that NHE3 activity may be
controlled by the traffic of the protein between a cyto-
plasmic compartment and the apical membrane. The
presence of NHE3 protein has been observed in subapi-
cal vesicular compartment in rat proximal tubule [9, 10]
and in human colon adenocarcinoma cell line Caco-2
expressing endogenous NHE3 [11]. NHE3 is present and
functional in recycling endosomes of fibroblasts activator
protein-1 (AP-1) transfected with a cDNA encoding
NHE3 [12]. A redistribution of NHE3 protein from api-
cal membrane to an intracellular compartment, associ-
ated with an inhibition of NHE3 activity, has been re-
ported in epithelia in several acute situations. This was
observed in kidney cortex during natriuresis-induced
acute hypertension in rats [13, 14], in Caco-2 cells follow-
ing phorbol ester application [11], and in kidney cortex
from rats injected with parathyroid hormone (PTH)
[15, 16]. Furthermore, in opossum kidney (OK) cells,
the PTH-induced NHE3 shift from the apical membrane
to an intracellular compartment is inhibited after tran-
sient expression of a dominant-negative guanine 5-tri-
phosphate (GTP)-binding defective mutant of dynamin,
which is consistent with endocytotic retrieval of NHE3
as a mechanism of inhibition [17]. Conversely, a redistri-
bution of NHE3 protein from intracellular compartment
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to apical membrane has also been recently reported in
short-term situations. In OK cell lines incubated in acid
medium or with endothelin, a stimulation of NHE3 activ-
ity is associated with a stimulation of exocytic insertion
of the protein to the apical membrane [18, 19].
Studies using cytochalasin D and latrunculin B (Sigma
Chemical Co., St. Louis, MO, USA), which disrupt the
actin cytoskeleton, suggest a role of the actin cytoskeleton
in the trafficking of NHE3 between a cytoplasmic com-
partment and the apical membrane [18–20]. Furthermore,
recent data support that phosphatidylinositol 3-kinase (PI
3-kinase) may be involved in intracellular vesicle recruit-
ment to the plasma membrane [21]. Inhibition of PI
3-kinase blocks glucose transporter protein, GLUT4,
translocation from the intravesicular pool to the plasma
membrane of adipocytes in response to insulin [22], and
suppresses the endosomal recycling of NHE3 to cell sur-
face in AP-1 fibroblasts transfected with NHE3 [23].
The purpose of the present study was to define the
role of NHE3 trafficking in the stimulation of NHE3
activity of proximal tubule by low-dose Ang II. We used
a non-transformed immortalized mouse kidney cortex
cell (MKCC) culture that was developed in our labora-
tory [24]. Indeed, MKCC line is highly differentiated
and retains properties of proximal tubule cells. This line
exhibits endogenous apical functional NHE3 and recep-
tors for Ang II [24]. The relative contribution of the
actin cytoskeleton and PI 3-kinase pathway was also
investigated. Results demonstrated that low-dose Ang
II–induced increase in NHE3 activity is due, at least in
part, to the stimulation of exocytic insertion of NHE3
into the apical membrane. This effect requires the integ-
rity of the actin cytoskeleton, and at least one step in
the transduction pathway involves PI 3-kinase.
METHODS
Cell culture
Mouse kidney cortical tubule culture cells (MKCC),
which were characterized previously, are a murine model
of proximal tubular cells and stably express NHE3.
NHE3 is present at the luminal brush border and in a
subapical cytoplasmic compartment as described before
[24]. MKCC, incubated in a humidified 5% CO2/95% air
atmosphere at 37C (pH 7.4), were grown on 6 cm Petri
dishes coated with extracellular matrix basement mem-
brane (matrix derived from Engelbreth-Holm-Swarm
mouse tumor; Harbor Bioproducts, Norwood, MA,
USA) at 5 to 6 days’ post-confluency in a medium that
was changed every two days [Dulbecco’s modified Ea-
gle’s medium (DMEM)/Ham’s F12; 1:1, vol/vol] [20
nmol/L sodium selenite, nonessential amino acids, 4
mmol/L glutamine, 33 mmol/L N-2-hydroxyethylpipera-
zine-N-2-ethanesulfonic acid (HEPES), 25 mmol/L
NaHCO3, 50 U/mL penicillin/streptomycin, 250 g/mL
amphotericin B, supplemented with 0.5 g/mL insulin,
1 mol/L triiodothyronin, 5g/mL transferrin, 10 ng/mL
cholera toxin, 10 ng/mL epidermal growth factor, 50
nmol/L dexamethasone, and 5% fetal calf serum (FCS)].
Cells were incubated in serum-free medium without hor-
mones or growth factors for 24 hours before the test.
Na uptake measurements
Na/H was assayed by a proton gradient–stimulated
initial rate of 22Na (Amersham, Buckinghamshire, UK)
uptake after cell acidification by an NH4 prepulse [25].
In experiments with Ang II, the hormone was present
in the medium during the time of acid-loading process
(43 minutes). Cells were washed and incubated for 30
minutes at 37C in NH4Cl medium containing [110 mmol/L
NaCl, 30 mmol/L NH4Cl, 10 mmol/L HEPES/Tris pH
7.4, 3 mmol/L KCl, 1 mmol/L CaCl2, 1 mmol/L MgCl2,
0.2 mmol/L KH2PO4, 0.8 mmol/L K2HPO4, 5 mmol/L
glucose, 5 mmol/L alanine, 5 mmol/L pyruvic acid, and
0.01% bovine serum albumin (BSA; Sigma Chemical
Co.)]. The cells were then incubated for an additional
period of 10 minutes in the same medium without Na
[equimolar substitution by tetramethylammonium chlo-
ride (TMA-Cl)]. The medium was removed, and 1 mL
of the uptake medium was added: [10 mmol/L 22NaCl,
0.05 Ci/mL, 10 mmol/L HEPES/Tris pH 7.4, 3 mmol/L
KCl, 1 mmol/L CaCl2, 1 mmol/L MgCl2, 130 mmol/L
TMA-Cl, and 2 mmol/L ouabain, 1 mol/L amiloride,
40 nmol/L bafilomycin with or without Na/H inhibitors,
ethylisopropylamiloride (EIPA; Sigma Chemical Co.), or
HOECHST 642 (HOE642)]. Under these conditions of
acid loading, 22Na uptake was linear with time for 6 min-
utes, and a time course of three minutes was selected for
22Na uptake. The reaction was stopped by 3 washes with an
ice-cold stop solution: 280 mmol/L mannitol, 20 mmol/L
HEPES/Tris, pH 7.4, and 0.5 mmol/L amiloride. The cells
were solubilized for 1 hour in 0.5 mL NaOH N2 before
splitting the samples for counting and protein assay. NHE3
activity is the activity resistant to 50 mol/L HOE642 and
sensitive to 300 mol/L EIPA.
Measurement of intracellular pH
Cells were dissociated with trypsin. Loading cell suspen-
sion with the pH-sensitive probe was achieved by incubation
for 20 minutes at 37C with [10mol/L 2’,7’-bis-(2-carboxy-
ethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester
(BCECF-AM)] in Na medium: 140 mmol/L NaCl, 3 mmol/L
KCl, 1 mmol/L CaCl2, 1 mmol/L MgCl2, 10 mmol/L
HEPES/Tris, pH 7.4. The cells were washed by 3 centrif-
ugations. The acid-load process was identical to the one
used for 22Na uptake experiments. Cells were then resus-
pended in NH4-free, Na-free–medium TMA medium
(140 mmol/L TMA-Cl, 3 mmol/L KCl, 1 mmol/L CaCl2,
1 mmol/L MgCl2, 10 mmol/L HEPES/Tris, pH 7.4). At
the end of the acid-load process (40 minutes), pHi was
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measured in control cells and in cells pretreated with
Ang II. BCECF fluorescence was monitored by using
Shimadzu RF-5000 spectrofluorometer (Shimadzu Co.,
Kyoto, Japan). Fluorescence was recorded with excita-
tion at 450 and 500 nm, and emission at 525 nm. The
values of the 500 to 450 nm fluorescence ratio were
converted into pHi values with use of calibration curves.
They were established for each sample after treatment
of the cells with 0.05% Triton X-100. The calibration
curves were linear (r 0.99), and there was no difference
between control and Ang II–treated cells. No difference
in pHi values was observed at the end of incubation time
between control and Ang II–treated cells (pHi, 6.46 
0.05 vs. 6.43  0.06; control vs. Ang II, NS, N  4).
Immunochemistry
Apical membranes of MKCC were biotinylated for 1
hour at 4C, described as follows. Cells were fixed with
3% paraformaldehyde in phosphate-buffered saline
(PBS) for 30 minutes at room temperature, incubated
for 5 minutes with 50 mmol/L NH4Cl, then washed with
PBS, and biotin was labeled with streptavidin-Cy5 (1
g/mL, 30 minutes at room temperature; Amersham,
Buckinghamshire, UK). After PBS washes, cells were
permeabilized with 0.1% Triton X-100 for 1 minute,
washed and incubated with Dako antibody diluent (Dako
Corporation, Carpinteria, CA, USA) for 10 minutes to
block nonspecific binding. Actin filaments were labeled
with 0.1 g/mL phalloidin-tetramethyl rhodamine iso-
thiocyanate (TRITC; Sigma Chemical Co.). The cells
were washed with PBS and mounted with Vectashield
(Vector Laboratories, Burlingame, CA, USA), then ob-
served with a Zeiss LSM 510 confocal microscope (Carl
Zeiss, Inc., Jena, Germany) using a 63 objective. The
cells were analyzed viewing horizontal and vertical (xz
series) sections through the cells. The staining of biotin
was strictly localized to apical membrane (Fig. 1A, left)
and the staining of actin showed both apical and basolat-
eral distribution (Fig. 1A, right).
Cell surface biotinylation
Cell surface biotinylation was performed on MKCC
as previously described [11]. Cells were grown on 6 cm
Petri dishes at 5 to 6 days’ post-confluency. Cells were
incubated in culture medium at 37C in 5% CO2/95%
air (pH 7.4), with or without treatment. Cells were then
washed 3 times at 4C with PBS-Ca-Mg, 137 mmol/L
NaCl, 2 mmol/L KCl, 8 mmol/L Na2HPO4, 1.5 mmol/L
KH2PO4, 0.1 mmol/L CaCl2, and 1 mmol/L MgCl2). The
surface plasma membrane proteins were then biotinyl-
ated for 1 hour at 4C [0.5 mL per dish of sulfosuccinimi-
dyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-biotin;
Pierce, Rockford, IL, USA)] in borate buffer (154
mmol/L NaCl, 10 mmol/L boric acid, 7.2 mmol/L KCl,
1.8 mmol/L CaCl2, pH 9). The biotinylation solution was
Fig. 1. Cultured proximal tubular cells (MKCC) were incubated for
24 hours in serum-free medium without hormones or growth factors.
(A ) MKCC were processed as described in Methods for confocal mi-
croscopy images of indirect immunofluorescence. The biotinylated pro-
teins labeled with streptavidin-Cy5 (1 g/mL) strictly localized in the
apical membrane (left), and actin cytoskeleton staining, labeled by using
tetramethylrhodamine isothiocyanate (TRICT)-phalloidin (0.1g/mL),
localized in both apical and basolateral membranes (right). Both confo-
cal microscopy images represent xz sections calculated from the same
set of xy images (lower band). (B) Typical immunoblot with increasing
concentrations of sulfo-NHS-LC-biotin or volumes of streptavidin-agarose.
Cell surface biotinylation was performed as described in Methods. Biotinyl-
ated proteins were isolated by precipitation with streptavidin-agarose and
subjected to 7.5% sodium dodecyl sulphate-polyacrimide gel electrophore-
sis (SDS-PAGE) and immunoblotting with anti-NHE3 antiserum (serum
1568, 1:5000 dilution). (C) Immunoblots of NHE3 protein in MKCC
homogenate (a) and in crude membranes of mouse kidney (b) labeled
with anti-NHE3 antiserum 1568 (left), and MKCC biotinylated NHE3
protein labeled with anti-NHE3 antisera 1568 and 1566 (both, 1:5000
dilution) (right). The two immunoreactive bands of NHE3 protein have
an observed mobility by SDS-PAGE of 78 and 66 kD.
then discarded and the cells washed 3 times with PBS
at 4C. Solubilization medium (500 L) consisting of
[150 mmol/L NaCl, 3 mmol/L KCl, 5 mmol/L ethylenedi-
aminetetraacetic acid (EDTA), 1% Triton X-100 (vol/vol),
and 60 mmol/L HEPES/Tris, pH 7.4 containing protein-
ase inhibitors (3 mol/L aprotinin, 20 mol/L phos-
phoramidon, 200 mol/L 4-(2-aminoethyl)-benzenesulfo-
nyl fluoride hydrochlorine (AEBSF), and 10 mol/L
leupeptin] were added to the monolayer for 45 minutes at
4C. Afterwards, the cells were sonicated and the resulting
homogenate was centrifuged 16,000g for 15 minutes at
4C. Supernatant (24 L) was taken to process Western
blots on cell lysate. The supernatant was incubated 45
minutes at 4C with streptavidin-agarose (Sigma Chemi-
cal Co.) to separate the biotinylated proteins from non-
biotinylated proteins by binding the former to streptavi-
din-agarose. After washes with lysis buffer, biotinylated
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proteins and homogenate were processed as described
for Western blot analysis. Immunoblotting with increas-
ing concentrations of biotin or volumes of streptavidin-
agarose shows that 1 mg/mL biotin combined with 50 L
streptavidin-agarose saturated all the binding sites for
NHE3 in the cells (Fig. 1B).
Endocytic internalization assay
Cells were labeled with 1 mg/mL sulfosuccinimidyl
2-(biotinamido)-ethyl-1, 3-dithiopropionate (sulfo-NHS-
SS-biotin; Pierce) and quenched as above. Cells were
then treated with 0.1 nmol/L Ang II or its vehicle for 43
minutes at 37C and rinsed 3 times with PBS-Ca-
Mg. Cells were then incubated at 4C in 2 mL of 10
mmol/L membrane-impermeant reducing agent 2-mer-
captoethanesulphonic acid (MESNA) in 100 mmol/L
NaCl, 1 mmol/L EDTA, 50 mmol/L Tris, and 0.2% BSA,
pH 8.6. An additional 0.5 mL of 50 mmol/L MESNA
was added to each plate at 30 minutes, and then an
additional 0.65 mL was added at 60 minutes as previously
described [19]. MESNA was then oxidized by the addi-
tion of 1 mL of 500 mmol/L iodoacetic acid for 10 min-
utes, and cells were lyzed with solubilization medium. The
biotinylated fraction, which represents nascent endo-
cyted surface protein, was precipitated with streptavidin-
agarose and subjected to sodium dodecyl sulphate-poly-
acrimide gel electrophoresis (SDS-PAGE) as described
in cell surface biotinylation and Western blot analysis.
To assess the efficiency of MESNA cleavage, experi-
ments were performed in which cells were maintained
at 4C after biotinylation to prevent endocytosis, and
then treated with MESNA.
Exocytic insertion assay
Cells were rinsed with PBS 3 times at room tempera-
ture, and the apical surface was incubated with 1.5
mg/mL sulfo-NHS-acetate (Pierce) in PBS-Ca-Mg
(pH 7.5) for 1 hour at 37C as previously described [18].
Cells were then washed with PBS-Ca-Mg at 37C
and incubated in Ang II or control media for 43 minutes.
MKCC were then washed 3 times and labeled with 1
mg/mL sulfo-NHS-LC-biotin at 4C. To verify the effi-
ciency of sulfo-NHS-acetate, biotinylation was performed
at 4C immediately after incubation at 4C with sulfo-
NHS-acetate. Biotinylated proteins were processed as
described for biotinylation and Western blot analysis.
Immunoblot analysis
Aliquots of 24 L of supernatant were mixed with 8L
Laemmli buffer, heated at 95C for 10 minutes, and
stored at 25C until use. Biotinylated proteins or ho-
mogenates (20 g) from MKCC, or of proteins issued
from microsome membranes of the whole kidney of a
wild-type mouse, determined by the method of Bradford
[26], were separated by SDS-PAGE (7.5%) according to
Laemmli [27], and transferred to 0.45 mm nitrocellulose
membranes Schleicher & Schuell (Dassel, Germany) by
using a Bio-Rad apparatus (Bio-Rad Laboratories, Her-
cules, CA, USA). Blots were rinsed and incubated over-
night at 4C with anti-NHE3 antiserum 1568, anti-NHE3
antiserum 1566 (dilution 1:5000), or rabbit polyclonal
anti-sodium glucose cotransporter 1 (SGLT1) antiserum
(dilution 1:50,000; Chemicon International, Inc., Teme-
cula, CA, USA). Both anti-NHE3 antisera raised to dif-
ferent cytoplasmic domains of rat NHE3 [aa 633 to 646
(YSRHELTPNEDEKQ), antiserum 1566; and aa 809
to 822 (DSLFQADGPEEQLQ), antiserum 1568]. After
treatment with the specific antibody, the nitrocellulose
membranes were washed and probed with horseradish
peroxidase-conjugated goat anti-rabbit antibody (Bio-
Rad Laboratories) and then developed with an enhanced
chemoluminescence kit (ECL). Polaroid pictures were
taken with an Amersham apparatus (Buckinghamshire,
UK). Apparent molecular masses were calculated on the
basis of the mobility of a panel of molecular mass mark-
ers from Sigma (Sigma Chemical Co.). Quantitative data
were obtained by scanning the photos (Scanjet cx Hew-
lett Packard using Deskan; Hewlett Packard Co., Palo
Alto, CA, USA) and analyzed with National Institutes
of Health (Bethesda, MD, USA) image software. In-
creasing amounts of the biotinylated proteins were loaded
to determine whether the analyzed NHE3 band densities
were within the linear portion of a concentration curve.
Data were normalized to protein loaded on the gel as
previously described [28].
Mouse kidney microsome preparation
for immunoblotting
The whole kidneys of a wild-type mouse were homoge-
nized in 1 mL of ice-cold isolation solution (50 mmol/L
Tris-HCl, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol,
250 mmol/L sucrose, pH 7.6, with 10 g/mL leupeptin
and 0.1 mg/mL phenylmethyl sulfonylfluoride) using a
Dounce homogenizer (Bellco Glass, Inc., Vineland, NJ,
USA) (with 10 strokes of the tight pestle). Nuclei and
debris were eliminated centrifugally at top speed (15,000g
for 10 minutes), and then the supernatant was centri-
fuged at 4000g for 15 minutes at 4C to produce pellet-
containing membrane fractions enriched for plasma mem-
branes and intracellular vesicles. Microsome membrane
samples were solubilized in Laemmli buffer [27], and
proteins were processed as described in Methods.
Statistics
Results are expressed as mean  standard error. Sta-
tistical significance was assessed by Student t test.
RESULTS
Low-dose angiotensin II increases NHE3 activity
MKCC stably express endogenous NHE3 and possess
functional Ang II receptors [24]. These cells thus appear
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Fig. 2. Low-dose angiotensin II (Ang II) (0.1 nmol/L) increased Na/H
exchanger 3 (NHE3) activity via angiotensin II receptor type 1 (AT1)
receptor activation in cultured proximal tubular cells (MKCC). MKCC
were incubated for 24 hours in serum-free medium without hormones
or growth factors, and then treated for 43 minutes at 37C with 0.1
nmol/L Ang II or vehicle in the absence or presence of AT1 receptor
inhibitor added 5 minutes before [AT1inh  losartan (10 mol/L) or
candesartan (1 nmol/L)]. NHE3 activity was measured by H-driven
initial rate of 22Na. NHE3 activity was defined as the activity resistant
to 50 mol/L Na/H exchange inhibitor cariporide (HOE642) and
sensitive to 300 mol/L ethyl isopropyl amiloride (EIPA). Values are
mean  SE of 9 experiments. *P 	 0.001 by paired t test. (, control;
, Ang II).
to be a powerful in vitro model for studying the cellular
mechanisms of the Ang II–induced regulation of NHE3
activity. Cells were incubated in the presence of 1010
mol/L Ang II or its vehicle for 43 minutes prior to the
measurement of the Na/H activity by the H-driven ini-
tial rate of 22Na uptake. NHE3 activity was defined as
the activity resistant to 50mol/L HOE642 and sensitive
to 300 mol/L EIPA [24]. As shown in Figure 2, low-
dose Ang II increased NHE3 activity by 56 11% (2.00
0.24 vs. 1.35  0.20 nmol/mg protein/3 minutes, Ang II
vs. control; P 	 0.001, N  9). In the presence of AT1-
receptor inhibitors, 10 mol/L losartan or 1 nmol/L can-
desartan, Ang II was no more able to stimulate NHE3
activity, indicating that the Ang II–induced activation
of NHE3 occurred via AT1 receptor. Note that in the
presence of AT1 receptor antagonists, Ang II reduced
NHE3 activity. This effect might be due to the activation
of AT2 receptors by Ang II, as recently suggested for the
Na-K-2Cl cotransporter (NKCC2) in macula densa
cells [29]. The mechanism of the inhibitory effect of Ang II
was beyond the scope of the study and was not analyzed
further.
Low-dose Ang II increases apical NHE3
protein abundance
Immunoblot analysis showed that the anti-NHE3 anti-
serum 1568 raised to rat NHE3 stained two bands at 78
and 66 kD (Fig. 1 B and C). These two bands were
extinguished by the immunizing peptide as already de-
scribed [20]. However, these bands have lower molecular
weights than usually observed (80 to 85 kD). Indeed, we
previously reported that in the rat the same anti-serum
blots a band around 80 kD in renal cortex homogenates
and apical membranes isolated from kidney cortical tu-
bules [20]. Thus, we cannot exclude that the antiserum
1568 recognizes in MKCC a protein-sharing epitope with
NHE3, but unrelated to NHE3. To test whether the two
bands observed in MKCC were specific for NHE3, we
first compared staining between MKCC homogenates
and mouse kidney microsomes with the anti-NHE3 anti-
serum 1568. The same labeling pattern was observed in
both preparations (Fig. 1C, left). Then we used a second
antiserum 1566 raised to a different cytoplasmic se-
quence of NHE3 (aa 633 to 646 for antiserum 1566 vs.
aa 809 to 822 for antiserum 1568). The same staining
was still observed in biotinylated MKCC with antiserum
1566 (Fig. 1C, right). Together, these results indicate
that the 78 and 66 kD bands labeled in MKCC very
likely represent NHE3.
We used cell surface biotinylation and Western blot
analysis to address whether the Ang II–induced increase
in NHE3 activity was associated with an increase in api-
cal NHE3 protein abundance. Pretreatment with low-
dose Ang II, 43 minutes, increased the abundance of cell
surface biotinylated NHE3 protein by 140  30% (P 	
0.05, N  3) (Fig. 3 A and B, left), whereas the total
amount of NHE3 protein abundance in cell homogenates
remained identical to control (Fig. 3A, middle). This
increase in cell surface biotinylated NHE3 was totally
blocked when 10 mol/L losartan was added to the incu-
bation medium 5 minutes before the exposure to Ang
II (Fig. 3 A and B, left). Lastly, to ascertain the specificity
of the Ang II effect observed on NHE3 protein abun-
dance, we tested whether the Na-glucose cotransporter
SGLT1, another apical membrane protein expressed in
MKCC, was affected by Ang II. As shown in Figure 3 A
and B, right, biotinylated SGLT1 protein abundance was
unaffected by Ang II treatment, indicating that the in-
crease in apical NHE3 protein abundance was specific
for NHE3.
Ang II–induced increase in apical NHE3 protein
abundance is not due to decreased
endocytic internalization
An increase in the amount of NHE3 protein at the
apical membrane could be due to increased exocytosis
or decreased endocytosis or a combination of both. To
measure endocytic internalization, MKCC were incu-
bated 60 minutes at 4C with sulfo-NHS-SS-biotin, then
43 minutes at 37C with 1010 mol/L Ang II or its vehicle.
Cells were then exposed to MESNA, which cleaves bio-
tin from NHE3 proteins remaining on the apical mem-
brane. Biotinylated NHE3 protein represents NHE3
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Fig. 3. Low-dose angiotensin II (Ang II) in-
creased apical Na/H exchanger 3 (NHE3)
protein abundance via angiotensin II receptor
type 1 (AT1) activation but did not affect api-
cal sodium glucose cotransporter 1 (SGLT1)
protein abundance in cultured proximal tu-
bule cells (MKCC). (A ) Typical blot of biotin-
ylated NHE3 protein (left), NHE3 protein in
homogenate (middle), and biotinylated SGLT1
protein (right). (B) Summary of results: MKCC
were incubated for 24 hours in serum-free me-
dium without hormones or growth factors.
Then, cells were pretreated with 0.1 nmol/L
Ang II or vehicle for 43 minutes in the absence
or presence of losartan (10 mol/L added 5
minutes before). Cell surface biotinylation
was performed with sulfosuccinimidyl-6-(bio-
tinamido) hexanoate (sulfo-NHS-LC-biotin)
(1 mg/mL) as described in Methods. Biotinyl-
ated proteins were isolated by precipitation
with streptavidin-agarose and subjected to
7.5% sodium dodecyl sulphate-polyacrimide
gel electrophoresis (SDS-PAGE) and immu-
noblotting with anti-NHE3 antiserum (serum
1568, 1:5000 dilution) or rabbit polyclonal
anti-SGLT1 antiserum (1:50,000 dilution). Re-
sults are mean  SE of 3 experiments. *P 	
0.05 by paired t test. (, control; , Ang II).
protein that was on the apical membrane at the beginning
of the experiments and intracellular at the end, after
internalization during the 43 minute exposure to Ang
II or vehicle. When biotinylated NHE3 abundance was
compared in cells not treated with MESNA and in cells
maintained at 4C to inhibit endocytosis and treated with
MESNA, 18 8% of biotinylated NHE3 was not cleaved
by MESNA (P 	 0.01 vs. control) (Fig. 4 A and B, left),
which means that MESNA-induced cleavage of biotin
from apical NHE3 was 82% effective. Compared with
cells not treated with MESNA, 45  5% of biotinylated
NHE3 was protected from MESNA after 43 minutes of
incubation with vehicle at 37C and was not different
from that observed with Ang II (Fig. 4 A and B, right).
When corrected from the 82% effectiveness of MESNA
cleavage, about 37% of apical NHE3 were internalized
in 43 minutes at 37C with vehicle or Ang II. These
data show that Ang II did not inhibit internalization of
biotinylated NHE3 protein, and suggest that the increase
in NHE3 protein abundance in apical membrane after
1010 mol/L Ang II exposure is not due to inhibition of
endocytosis.
Ang II–induced increase in apical NHE3 protein
abundance is due to increased exocytic insertion
To study exocytic insertion, endocytosis was inhibited.
MKCC were pretreated for 1 hour with sulfo-NHS-ace-
tate, which blocked all apical protein reactive sites, prior
to the addition of 1010 mol/L Ang II for 43 minutes
or vehicle, and cell surface biotinylation. Biotinylated
NHE3 represented the protein that was intracellular at
the beginning of the experiment (protected from sulfo-
NHS-acetate) and on the apical membrane at the end.
After pretreatment with sulfo-NHS-acetate, 30  6% of
biotinylated NHE3 protein were immunodetected com-
pared to non-treated controls (P 	 0.05) (Fig. 5 A and
B, left), which indicates that sulfo-NHS-acetate blocking
of apical reactive sites was 70% effective. In response
to Ang II, a 55  9% increase in labeled NHE3 protein
in the apical membrane was observed on sulfo-NHS-
acetate–treated cells (P 	 0.01 vs. control) (Fig. 5 C and
D, right). It was verified by Western blot that the amount
of NHE3 in total cell extract remained unchanged upon
Ang II treatment (data not shown). These results suggest
that low concentrations of Ang II increase apical NHE3
protein abundance by a stimulation of exocytic insertion.
PI 3-kinase mediates Ang II–induced increase in
NHE3 activity and apical membrane NHE3 abundance
PI 3-kinase has been implicated in NHE3 trafficking
in AP1 fibroblasts transfected with NHE3 [23]. To deter-
mine whether PI 3-kinase is involved in Ang II–induced
NHE3 stimulation in MKCC, we examined the effect of
wortmannin (Sigma Chemical Co.), a selective inhibitor
of PI 3-kinase activity at concentrations up to 100 nmol/L
[30–32]. Wortmannin (100 nmol/L) was added 15 min-
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Fig. 4. Low-dose angiotensin II (Ang II)–induced increase in apical
Na/H exchanger 3 (NHE3) protein abundance was not due to decrease
in NHE3 internalization. (A ) Typical blots. (B ) Summary of results:
cultured proximal tubule cells (MKCC) were incubated for 24 hours
in serum-free medium without hormones or growth factors. Then, cells
were incubated for 1 hour with sulfosuccinimidyl 2-(biotinamido)-ethyl-
1, 3-dithiopropionate (sulfo-NHS-SS-biotin) (1 mg/mL), treated at 37C
with 0.1 nmol/L Ang II or vehicle for 43 minutes, or maintained at
4C, and incubated with 2-mercaptoethanesulphonic acid (MESNA) as
described in Methods. Biotinylated proteins were isolated by precipita-
tion with streptavidin-agarose and subjected to 7.5% sodium dodecyl
sulphate-polyacrimide gel electrophoresis (SDS-PAGE) and immu-
noblotting with anti-NHE3 antiserum (serum 1568, 1:5000 dilution).
Results were compared with cells not treated with MESNA and ex-
pressed as internalized NHE3 protein in percent of apical NHE3 pro-
tein. Results are mean  SE of 4 experiments. *P 	 0.01 vs. control
by paired t test. (, control; , Ang II).
utes prior to addition of Ang II. As shown in Figure 6A,
in the absence of inhibitor, low-dose Ang II caused a 84
43% increase in NHE3 activity (1.72  0.22 vs. 1.04 
0.17 nmol/mg prot/3 minutes, Ang II vs. controls, P 	
0.05, N  5). Wortmannin pretreatment completely in-
hibited this Ang II–induced increase in NHE3 activity
(Fig. 6A, right). Therefore, the stimulation of NHE3 activ-
ity by low-dose Ang II is under control of PI 3-kinase.
Then, we examined, by cell surface biotinylation, the
possibility that PI 3-kinase also mediates Ang II–induced
NHE3 apical membrane insertion. In the absence of
wortmannin, Ang II elicited a 59  14% increase in
apical NHE3 protein abundance (P 	 0.02, N  5) (Fig-
ure 6 B and C, left), and this effect was no longer ob-
served upon the addition of wortmannin (Fig. 6 B and
C, right). These data are consistent with a PI 3-kinase–
mediated stimulation of exocytic insertion of NHE3 pro-
tein in the luminal membrane leading to a rise in luminal
NHE3 activity.
Fig. 5. Low-dose angiotensin II (Ang II) increased apical Na/H ex-
changer 3 (NHE3) protein abundance by exocytic insertion activation.
(A and C ) Typical blots. (B and D ) Summary of results: cultured
proximal tubule cells (MKCC) were incubated for 24 hours in serum-
free medium without hormones or growth factors. Then, cells were incu-
bated for 1 hour with sulfo-NHS-acetate (1.5 mg/mL) and immediately
incubated with sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-
LC-biotin) at 4C (A and B) or treated with 0.1 nmol/L Ang II or vehicle
for 43 minutes (C and D). Cell surface biotinylation was next performed
with sulfo-NHS-LC-biotin (1 mg/mL) as described in Methods. Biotinyl-
ated proteins were isolated by precipitation with streptavidin-agarose
and subjected to 7.5% sodium dodecyl sulphate-polyacrimide gel elec-
trophoresis (SDS-PAGE) and immunoblotting with anti-NHE3 antise-
rum (serum 1568, 1:5000 dilution). Results are mean  SE of 3 experi-
ments and expressed in percent of control. *P 	 0.01 and **P 	 0.05
by paired t test. (, control; , Ang II).
Actin cytoskeleton disruption blocks low-dose Ang
II–induced increase in NHE3 activity and apical
membrane NHE3 protein abundance
To determine if actin cytoskeleton was required for
the stimulatory effect of Ang II on NHE3 activity and
apical abundance, MKCC were incubated with 10 mol/L
latrunculin B (Lat B), an inhibitor of actin filament poly-
merization. As shown in Figure 7A, left, in the absence
of Lat B, Ang II caused a 53  12% increase in NHE3
activity (2.58  0.22 vs. 1.71  0.16 nmol/mg prot/3 min-
utes, Ang II vs. control, P 	 0.01, N  5), and Lat B
inhibited this effect (Fig. 7A, right). Moreover, as shown
in Figure 7 B and C, left, in the absence of Lat B, Ang II
caused a 55  5% increase in NHE3 apical abundance
(P 	 0.01, N  5). Lat B also inhibited this effect (Fig.
7 B and C, left). Altogether, these data strongly support
that actin cytoskeleton integrity plays a key role in Ang II–
induced increase in apical membrane NHE3 protein
abundance and that trafficking of NHE3 protein is re-
quired for Ang II to increase NHE3 activity.
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Fig. 6. Phosphatidylinositol (PI) 3-kinase mediated angiotensin II
(Ang II)–induced increase in Na/H exchanger 3 (NHE3) activity
and apical NHE3 protein abundance in cultured proximal tubule cells
(MKCC). MKCC were incubated for 24 hours in serum-free medium
without hormones or growth factors. (A ) Cells were treated 43 minutes
with 0.1 nmol/L Ang II at 37C or vehicle in the presence of wortmannin
(100 nmol/L added 15 minutes before) or its vehicle [0.1% dimethyl
sulfoxide (DMSO) vol/vol]. Na/H exchanger activity was measured by
H-driven initial rate of 22Na. NHE3 activity was the activity resistant
to 50 mol/L Na/H exchange inhibitor cariporide (HOE642) and
sensitive to 300 mol/L ethyl isopropyl amiloride (EIPA). Results are
mean  SE of 5 experiments. *P 	 0.05 vs. control by paired t test.
(, control; , Ang II). (B ) Typical blots. (C ) Summary of results for
biotinylated NHE3 protein. Cells were treated 43 minutes with 0.1
nmol/L Ang II at 37C or vehicle in presence of wortmannin (100 nmol/L
added 15 minutes before) or its vehicle [0.1% dimethyl sulfoxide (DMSO),
vol/vol]. Cell surface biotinylation was performed with sulfosuccinimidyl-
6-(biotinamido) hexanoate (sulfo-NHS-LC-biotin) (1 mg/mL) as de-
scribed in Methods. Biotinylated proteins were isolated by precipitation
with streptavidin-agarose and subjected to 7.5% sodium dodecyl sulphate-
polyacrimide gel electrophoresis (SDS-PAGE) and immunoblotting
with anti-NHE3 antiserum (serum 1568 1:5000 dilution). Results are
mean  SE of 5 experiments. *P 	 0.02 vs. control by paired t test.
(, control; , Ang II).
Fig. 7. Actin cytoskeleton integrity was required for angiotensin II
(Ang II)–induced increase in Na/H exchanger 3 (NHE3) activity
and apical NHE3 protein abundance in cultured proximal tubule cells
(MKCC). MKCC were incubated for 24 hours in serum-free medium
without hormones or growth factors. (A ) Cells were treated 43 minutes
with 0.1 nmol/L Ang II at 37C or vehicle in the presence or absence
of 10 mol/L latrunculin B. Na/H exchanger activity was measured by
H-driven initial rate of 22Na. NHE3 activity was the activity resistant
to 50 mol/L Na/H exchange inhibitor cariporide (HOE642) and
sensitive to 300 mol/L ethyl isopropyl amiloride (EIPA). Results are
mean  SE of 5 experiments. *P 	 0.01 vs. Ang II alone, **P 	 0.01
vs. control by paired t test. (, control; , Ang II). (B ) Typical blots.
(C ) Summary of results for biotinylated NHE3 protein. Cells were
treated 43 minutes with 0.1 nmol/L Ang II at 37C or vehicle in presence
or absence of 10 mol/L latrunculin B or its vehicle [0.1% dimethyl
sulfoxide (DMSO) vol/vol]. Cell surface biotinylation was performed
with sulfosuccinimidyl-6-(biotinamido) hexanoate (sulfo-NHS-LC-bio-
tin) (1 mg/mL) as described in Methods. Biotinylated proteins were
isolated by precipitation with streptavidin-agarose and subjected to
7.5% sodium dodecyl sulphate-polyacrimide gel electrophoresis (SDS-
PAGE) and immunoblotting with anti-NHE3 antiserum (serum 1568,
1:5000 dilution). Results are mean  SE of 5 experiments. **P 	 0.001
vs. control. (, control; , Ang II).
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DISCUSSION
The present study, carried out on differentiated mu-
rine proximal tubule cell culture (MKCC) expressing
endogenously NHE3 and AT1 receptors [24], was de-
signed to define whether NHE3 trafficking was involved
in the low-dose Ang II–induced stimulation of the apical
Na/H exchanger NHE3 activity. The main novel points
are the following: (1) low-dose Ang II–induced stimula-
tion of NHE3 activity was associated with an increased
apical NHE3 protein abundance without modification of
the total amount of NHE3 protein in cell homogenates,
and both effects were suppressed by AT1 receptor antag-
onists; (2) Ang II–induced increase in luminal membrane
NHE3 abundance was due, at least in part, to stimulation
of exocytic insertion of the protein; (3) Ang II–induced
increase in apical NHE3 protein abundance and NHE3
activity was prevented by wortmannin, which supports a
role of PI 3-kinase; and (4) actin cytoskeleton disruption
blocked Ang II stimulating effect on NHE3 activity and
trafficking.
Ang II, at low concentrations, stimulates NaCl and
HCO3 absorption in the renal proximal tubule by activa-
tion of the apical Na/H exchanger NHE3. This effect
was repeatedly documented by groups using different
experimental models, in vivo microperfusion [33], or in
vitro microperfusion studies [34], tubule suspensions
[3, 35], brush border membrane vesicles [7], and cultured
cell line [1]. This effect occurs mainly via AT1 receptor
activation [1–3, 36]. In our mouse cultured cell model,
MKCC, which stably express endogenous NHE3, the
Ang II–induced stimulation of NHE3 activity was con-
firmed. By immunoblot analysis, two immunoreactive
bands of 78 and 66 kD were detected in MKCC and in
mouse renal microsomes, with two well-characterized
polyclonal antibodies to NHE3 protein. Since NHE3
protein is usually described as a monomer of between
80 to 85 kD either in rat [9, 37] or in mouse [38], the
difference in the immunolabeled bands corresponding
to NHE3 between the studies could be explain by differ-
ences in membrane preparation. Nonetheless, we ob-
served that the Ang II–induced increase in NHE3 activity
was associated with an increase in the abundance of
biotinylated NHE3 protein in the apical membrane.
When we pooled the results of the three series of experi-
ments describing the effects of Ang II on NHE3 activity
and apical membrane abundance, shown in Figures 2, 3,
6, and 7, the mean increase in NHE3 activity (73 20%,
N  19) was of similar magnitude as that observed for
NHE3 apical abundance (76  13%, N  13). AT1
receptor antagonists inhibited both increased NHE3 ac-
tivity and apical abundance induced by Ang II. Taken
together, these results suggest that increased NHE3 in-
sertion in the apical membrane plays a key role in the
increase in NHE3 activity induced by Ang II. In addition,
the effect of Ang II is very likely specific for NHE3,
since biotinylated SGTL1 protein abundance in the api-
cal membrane remained unchanged in the presence of
Ang II.
The relative contribution of increased exocytic inser-
tion or decreased endocytic internalization in the Ang
II–induced increase in apical NHE3 protein abundance
was then analyzed. Endocytic internalization of NHE3
was not affected by Ang II. Under basal conditions, about
37% of apical NHE3 was internalized in 43 minutes at
37C, which probably represents the net effect of apical
membrane recycling of NHE3 in MKCC. Note that the
basal endocytic internalization rate of NHE3 seems to
be at least in part cell-specific. The value reported is
higher in AP-1 cells transfected with NHE3, about 70%
in 30 minutes at 37C [23], and lower in OK cells, about
5% in 35 minutes at 37C [19]. In MKCC, the Ang II–
induced increased in apical NHE3 abundance was due
to a selective increase in exocytic insertion of the trans-
porter. The additional 55% of NHE3 that was inserted
in the apical membrane is of the same order of magnitude
as the mean increase in apical NHE3 abundance.
The importance of actin cytoskeleton in processes
leading to exocytic insertion of NHE3 protein during
stimulation by Ang II was analyzed using Lat B. Actin
cytoskeleton disruption by Lat B inhibited Ang II–
induced increase in both apical NHE3 protein abundance
and NHE3 activity. Taken together these results demon-
strate, that acute stimulation of NHE3 activity by Ang
II results at least in part from stimulation of exocytic
insertion of NHE3 protein, which requires actin cytoskel-
eton integrity. Interestingly, in OK cell lines either incu-
bated in acid medium or with endothelin, the increased
exocytic insertion of the NHE3 protein was also inhibited
by Lat B [18, 19].
The present study shows that the Ang II–induced in-
crease in apical NHE3 abundance and activity was pre-
vented by wortmannin, which suggests a role of PI 3-kinase.
Previous studies have shown a role of PI 3-kinase in
the stimulation of NHE3 activity. In Caco-2 cells stably
transfected with NHE3 (Caco-2-/NHE3 cells), acute EGF-
induced stimulation of NHE3 activity is inhibited by wor-
tmannin, and EGF stimulates PI 3-kinase activity [39].
In PS 120 fibroblasts, Chinese hamster lung fibroblasts,
stably expressing NHE3 (PS120/NHE3 cells), the stimu-
lation of PI 3-kinase activity by a synthetic peptide stimu-
lator of PI 3-kinase or transient infection with adenovirus
containing constitutively active PI 3-kinase increases NHE3
activity [40]. The hypo-osmolality-induced increase in
NHE3-dependent absorption of bicarbonate in intact
medullary ascending limb of rat kidney is inhibited by
wortmannin [41]. In addition, a role of PI 3-kinase in
the stimulation of intracellular vesicle recruitment to cell
surface has been recently proposed. Wortmannin and
dominant-negative PI 3-kinase block the insulin-induced
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GLUT4 translocation from intravesicular pool to plasma
membrane in adipocytes [22, 42]. PI 3-kinase inhibition
blocks the delivery of recycling endosomes to the cell
surface [43]. Inhibition of PI 3-kinase inhibits endosomal
recycling of NHE3 to cell surface in AP-1 fibroblasts trans-
fected with NHE3 [23]. In the present study, PI 3-kinase
inhibition prevented the Ang II–induced increase in api-
cal NHE3 protein abundance and activity in MKCC.
This is the first demonstration, to our knowledge, of a
role of PI 3-kinase in the stimulation of translocation of
NHE3 from cytosolic compartment to apical membrane
of epithelium cells. Note that under basal conditions, in
MKCC possessing endogenously NHE3, wortmannin did
not affect NHE3 activity and apical membrane protein
abundance. These results seems to be at variance with
the reduction of NHE3 activity and endosomal recycling
observed in AP-1 cells transfected with NHE3 after PI
3-kinase inhibition [23]. The differences are probably ex-
plained, at least in part, by the lower basal rates of the
endosomal recycling in MKCC, compared to heteroge-
nously NHE3 transfected AP-1 cells.
The signalization downstream PI 3-kinase, which might
control the insertion of NHE3 in the apical membrane
of MKCC, is not established, but Akt/protein kinase B
is a possible candidate. In PS120/NHE3 cells, the stimula-
tion of PI 3-kinase alone by either a synthetic peptide
binding polyphosphoinositides or transient infection with
adenovirus containing constitutively active PI 3-kinase,
increases NHE3 activity and plasma membrane abun-
dance, and also stimulates Akt activity [40]. In addition,
activation of Akt activity alone with the inducible adenovi-
rus expression system causes a stimulation of NHE3 activ-
ity of similar magnitude as that observed with the activa-
tion of PI 3-kinase alone [40]. Together, these results
suggest that most of the PI 3-kinase stimulation of NHE3
activity may be due to activation of Akt in PS120/NHE3
cells. Accordingly, the PI 3-kinase/Akt cascade might
also control, at least in part, the final NHE3 exocytosis
induced by Ang II in MKCC.
CONCLUSION
The present data provide evidence that, in a differenti-
ated murine proximal tubule cell line, the Ang II–
induced increase in NHE3 activity is due, at least in part,
to the stimulation of exocytic insertion of NHE3 protein
into the apical membrane. This effect requires the integ-
rity of actin cytoskeleton and involves PI 3-kinase.
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